Verified Nov 2026
Other
·
Tel Aviv-Yafo, Tel Aviv District
·
Since 1901
Teva Pharmaceuticals, headquartered in Tel Aviv-Yafo, Israel, is a multinational biopharmaceutical company founded in 1901 with 10,000–50,000 employees and revenue exceeding $10 billion. It is generic drug manufacturer, serving approximately 200 million people daily across 57–60 markets. The company develops complex generics, biosimilars, therapies, and over-the-counter products for central nervous system disorders, respiratory diseases, oncology, and dermatology. Recent developments include a partnership expansion with Samsung Bioepis to commercialize biosimilars in the United States.
Teva Pharmaceuticals at a glance
Revenue
$10B+
Est. band
Employees
10,000-50,000
Founded
1901
Headquarters
Tel Aviv-Yafo, Tel Aviv District
Import activity
15162
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
15162
Named foreign suppliers
50
Top origins
Israel · Germany · Netherlands · Belgium

Shared foreign counterparties do not establish that these companies buy from Teva Pharmaceuticals.
What this tells a buyer
Teva recorded 15,162 shipments across customs records, with primary manufacturing sources in Israel, Croatia, and Czech Republic, supplemented by contract manufacturing partners in Austria, the United Kingdom, and Italy.
The company operates 53 manufacturing facilities across 33 countries and manufactures complex generics, biosimilars, active pharmaceutical ingredients, and branded medicines.
With approximately 37,000 employees, Teva ranks among the top pharmaceutical companies worldwide and serves patients in healthcare systems globally through an extensive product portfolio and contract manufacturing services.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
125 years in operation (founded 1901).
15,162 US import shipments on record.
Overview
Teva Pharmaceuticals, headquartered in Tel Aviv-Yafo, Israel, is a multinational biopharmaceutical company founded in 1901 with 10,000–50,000 employees and revenue exceeding $10 billion. It is generic drug manufacturer, serving approximately 200 million people daily across 57–60 markets. The company develops complex generics, biosimilars, therapies, and over-the-counter products for central nervous system disorders, respiratory diseases, oncology, and dermatology. Recent developments include a partnership expansion with Samsung Bioepis to commercialize biosimilars in the United States.
At a glance
Attribute | Detail |
|---|---|
Founded | 1901 |
Headquarters | Tel Aviv-Yafo, Tel Aviv District |
Employees | 10,000-50,000 |
Revenue | $10B+ (estimated) |
What Teva Pharmaceuticals makes
The company operates 53 manufacturing facilities across 33 countries and manufactures complex generics, biosimilars, active pharmaceutical ingredients, and branded medicines.
Trade and customs footprint
Teva recorded 15,162 shipments across customs records, with primary manufacturing sources in Israel, Croatia, and Czech Republic, supplemented by contract manufacturing partners in Austria, the United Kingdom, and Italy. US customs bill-of-lading records list 15162 inbound shipments across 50 foreign suppliers, with top origins including Israel · Germany · Netherlands · Belgium.
Latest developments
2026-11-13 — Teva CEO 'proud' of pipeline buzz as innovative-generics hybrid rolls out 1st R&D day | Fierce Pharma (fiercepharma.com)
2026-11-03 — Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S. (tevapharm.com)
2026-11-03 — Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for (tevapharm.com)
2026-10-27 — Teva Pharmaceutical Industries Ltd. - Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline (tevapharm.com)
2026-10-01 — Teva Pharmaceutical Industries Ltd. - Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates (tevapharm.com)
2026-09-08 — Andarta Therapeutics to Advance Parkinson’s Disease Research through Agreement with Teva and Grant from The Michael J. Fox Foundation (tevapharm.com)
Company details
With approximately 37,000 employees, Teva ranks among the top pharmaceutical companies worldwide and serves patients in healthcare systems globally through an extensive product portfolio and contract manufacturing services. Teva Pharmaceuticals was founded in 1901, has an estimated 10,000-50,000 employees, and is headquartered in Tel Aviv-Yafo, Tel Aviv District. On the LightSource stability read it is rated "Established & active": 125 years in operation (founded 1901). 15,162 US import shipments on record.
Frequently asked questions
What does Teva Pharmaceuticals do?
Teva Pharmaceuticals, headquartered in Tel Aviv-Yafo, Israel, is a multinational biopharmaceutical company founded in 1901 with 10,000–50,000 employees and revenue exceeding $10 billion. It is generic drug manufacturer, serving approximately 200 million people daily across 57–60 markets. The company develops complex generics, biosimilars, therapies, and over-the-counter products for central nervous system disorders, respiratory diseases, oncology, and dermatology. Recent developments include a partnership expansion with Samsung Bioepis to commercialize biosimilars in the United States.
Where is Teva Pharmaceuticals headquartered?
Teva Pharmaceuticals is headquartered in Tel Aviv-Yafo, Tel Aviv District (124 דבורה הנביאה, Tel Aviv-Yafo, Tel Aviv District, 60000).
When was Teva Pharmaceuticals founded?
Teva Pharmaceuticals was founded in 1901.
How big is Teva Pharmaceuticals?
Teva Pharmaceuticals has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).
Does Teva Pharmaceuticals import from overseas suppliers?
US customs bill-of-lading records show 15162 inbound shipments for Teva Pharmaceuticals, with top origins including Israel · Germany · Netherlands · Belgium.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
